Get started
Author

Mariana Yoncheva-Mihaylova

Observed names: Mariana Dimitrova Yoncheva-Mihaylova, Yoncheva-Mihaylova, Mariana
Observed institution: Military Medical Academy
ORCID: 0009-0003-1263-0675
Observed ORCID: 0009-0003-1263-0675
OpenAlex ID: A5018155807
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 3,345
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 665
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 242
PDF
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 125
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 41
PDF
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
2023 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 1
PDF
Implantation of ICD in a patient with heart failure with mildly reduced ejection fraction
2025 · Denislav Emilov Biserov, Mariana Dimitrova Yoncheva-Mihaylova · World Journal of Advanced Research and Reviews
PDF
Approaches to health technology assessment of innovative treatments for type 2 diabetes mellitus
2023 · Йончева-Михайлова, Мариана, Yoncheva-Mihaylova, Mariana · Bulgarian Portal for Open Science
Works count: 9
Citation count: 4,419
H-index: 5
I10-index: 5
Year
Topic
Type